Zynerba Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Devon, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Zynerba Pharmaceuticals, Inc. has filed 526 SEC EDGAR filings since 09 Oct 2014

SEC filing history

Showing 101-125 of 526 matching filings.

Per page
25
Current page
5
424B5 File 333-264966

424B5

Filing date
21 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
20 Jul 2022
Reporting date
18 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
20 Jul 2022
Reporting date
18 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
20 Jul 2022
Reporting date
18 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
20 Jul 2022
Reporting date
18 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-264966

EFFECT filing

Filing date
10 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .